Onderzoeker
Len Verbeke
- Disciplines:Gastro-enterologie en hepatologie, Immunologie, Pediatrie en neonatologie, Verpleegkunde
Affiliaties
- Hepatologie (Afdeling)
Lid
Vanaf1 okt 2010 → 30 sep 2019
Projecten
1 - 1 of 1
- De rol van microcirculaire dysfunctie, het aangeboren immuunsysteem en intestinale permeabiliteit in de vroege fase van acuut-op-chronisch leverfalen.Vanaf1 okt 2010 → 30 sep 2015Financiering: FWO mandaten
Publicaties
11 - 20 van 32
- Steroidal or non-steroidal FXR agonists - Is that the question?(2017)
Auteurs: Len Verbeke, Frederik Nevens, Wim Laleman
Pagina's: 680 - 681 - Steroidal or non-steroidal FXR agonists - Is that the question?(2017)
Auteurs: Len Verbeke, Frederik Nevens, Wim Laleman
Pagina's: 680 - 681 - Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats(2017)
Auteurs: Laurens Ceulemans, Len Verbeke, Jean-Paul Decuypere, Ricard Farré Marti, Gert De Hertogh, Ina Jochmans, Diethard Monbaliu, Frederik Nevens, Jan Tack, Wim Laleman, et al.
- Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis(2017)
Auteurs: Len Verbeke, Wim Laleman
Pagina's: 145 - 155 - Evolving insights in the pathophysiology of complications of cirrhosis: The farnesoid X receptor (FXR) to the rescue?(2016)
Auteurs: Wim Laleman, Len Verbeke
Pagina's: 1792 - 1794 - The expanding role of the bile acid receptor farnesoid X in the intestine and its potential clinical implications(2016)
Auteurs: Laurens Ceulemans, Emilio Canovai, Len Verbeke, Jacques Pirenne, Ricard Farré Marti
Pagina's: 156 - 163 - IN TOXIC CIRRHOTIC RATS, THE FXR AGONIST OBETICHOLIC ACID REDUCES LIVER FIBROSIS INDIRECTLY VIA AN ANTI-INFLAMMATORY EFFECT IN LIVER SINUSOIDAL ENDOTHELIAL CELLS AND KUPFFER CELLS(2016)
Auteurs: Len Verbeke, I Mannaerts, R Schierwagen, Olivier Govaere, Sam Klein, Ingrid Vander Elst, Petra Windmolders, Ricard Farre, Mathias Wenes, Max Mazzone, et al.
Pagina's: S141 - S141 - WHEN IS INTENSIVE CARE TREATMENT FUTILE IN PATIENTS WITH ORGAN FAILURE AND END-STAGE LIVER DISEASE?(2016)
Auteurs: KP Lindvig, M Thiele, V Fuhrmann, Wim Laleman, K Roedl, Len Verbeke, K Faber, T Strom, J O'Beirne, P Toft, et al.
Pagina's: S166 - S166 - FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis(2016)
Auteurs: Len Verbeke, Olivier Govaere, Ricard Farré Marti, Mathias Wenes, Max Mazzone, Frederik Nevens, Wim Laleman
- Prednisolone or Pentoxifylline for Alcoholic Hepatitis(2015)
Auteurs: Len Verbeke, W Laleman, Frederik Nevens
Pagina's: 281